Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 1019-1020
DOI: 10.1111/apt.70854 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-07-10. Written by Søren S Olesen and 1 co-authors. Institution: Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark. 5 references. The full text is freely available in PubMed Central.
Abstract (original language)
Intet abstract tilgængeligt.
Authors and institutions
- Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
ORCID profiles: Søren S Olesen, Asbjørn M Drewes
Cite
APA
Olesen, S. S., & Drewes, A. M. (2026). Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(7), 1019-1020. https://doi.org/10.1111/apt.70854
Vancouver
Olesen SS, Drewes AM. Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(7):1019-1020. doi:10.1111/apt.70854
BibTeX
@article{Olesen2026,
author = {Olesen, Søren S and Drewes, Asbjørn M},
title = {Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {7},
pages = {1019--1020},
doi = {10.1111/apt.70854}
}
EUVIMED